Nektar Therapeutics
NKTR
$1.15
Share price
-4.26%
Change (1 day)
-6.20%
Change (1 year)
Categories
Nektar Therapeutics (NKTR) - Total liabilities
Total liabilities on the balance sheet as of December 2024 : C$0.34 Billion
According to Nektar Therapeutics 's latest financial reports the company's total liabilities are C$0.34 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | C$0.34 B | -1.51% |
| 2023-12-31 | C$0.35 B | -24.11% |
| 2022-12-31 | C$0.46 B | -16.32% |
| 2021-12-31 | C$0.55 B | -5.2% |
| 2020-12-31 | C$0.58 B | -21.23% |
| 2019-12-31 | C$0.74 B | 26.77% |
| 2018-12-31 | C$0.58 B | 11.32% |
| 2017-12-31 | C$0.52 B | -18.06% |
| 2016-12-31 | C$0.64 B | -5.38% |
| 2015-12-31 | C$0.68 B | 45.17% |
| 2014-12-31 | C$0.47 B | -15.75% |
| 2013-12-31 | C$0.55 B | 24.54% |
| 2012-12-31 | C$0.44 B | 7.81% |
| 2011-12-31 | C$0.41 B | -3.4% |
| 2010-12-31 | C$0.43 B | -13.55% |
| 2009-12-31 | C$0.49 B | 10.55% |
| 2008-12-31 | C$0.45 B | -11.6% |
| 2007-12-31 | C$0.50 B | -19.14% |
| 2006-12-31 | C$0.63 B | 1.77% |
| 2005-12-31 | C$0.61 B | 85.69% |
| 2004-12-31 | C$0.33 B | -43.21% |
| 2003-12-31 | C$0.58 B | -7.04% |
| 2002-12-31 | C$0.63 B | -0.12% |
| 2001-12-31 | C$0.63 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | C$122.95 B | 35,258.87% | 🇺🇸 USA |
 | C$178.64 B | 51,274.88% | 🇺🇸 USA |
 | C$101.17 B | 28,995.11% | 🇺🇸 USA |
 | C$55.83 M | -83.94% | 🇺🇸 USA |
 | C$90.34 B | 25,881.33% | 🇬🇧 UK |
 | C$26.82 B | 7,615.75% | 🇺🇸 USA |
 | C$0.84 B | 142.93% | 🇮🇪 Ireland |
 | C$155.35 B | 44,576.34% | 🇺🇸 USA |